Sharda Cropchem
- P/E
- 9.77
Key Fundamentals
MicrocapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 30.20%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹69.41
- Book Value
- ₹360.23
- Market Cap
- —
- P/E (TTM)
- 9.77
- P/B
- 1.88
- ROE
- 23.20%
- Dividend Yield
- 2.23%
- EBITDA
- ₹1,182 Cr
- 52W High
- ₹1,297.00
- 52W Low
- ₹622.50
- Day Range
- ₹658.45 – ₹680.40
- Volume
- 1,07,760
Peer Comparison
Commodities › Chemicals › Pesticides & Agrochemicals
| ₹529.00 | 22.09 | ₹43,728 Cr | 1.28 | 1.16% | 5.64% | 10.10% | ₹52,804 Cr | ₹2,323 Cr | |
| ₹2,187.00 | 28.48 | ₹33,248 Cr | 2.95 | 0.69% | 11.20% | 15.00% | ₹6,516 Cr | ₹1,164 Cr | |
| ₹328.10 | 28.24 | ₹15,980 Cr | 4.43 | 0.41% | 17.60% | 23.50% | ₹3,192 Cr | ₹581 Cr | |
| ₹3,249.90 | 19.95 | ₹14,602 Cr | 4.92 | 4.57% | 23.70% | 29.10% | ₹5,595 Cr | ₹733 Cr | |
| Sharda Cropchem (this company) | ₹677.95 | 9.77 | ₹6,015 Cr | 1.88 | 2.23% | 23.20% | 30.20% | ₹5,357 Cr | ₹626 Cr |
| ₹942.75 | 15.83 | ₹4,217 Cr | 2.50 | 0.21% | 18.50% | 23.80% | ₹1,953 Cr | ₹268 Cr | |
| ₹189.67 | 17.23 | ₹3,734 Cr | 1.68 | 1.58% | 10.20% | 14.10% | ₹2,962 Cr | ₹214 Cr | |
| Median 7 companies | ₹677.95 | 19.95 | ₹14,602 Cr | 2.50 | 1.16% | 17.60% | 23.50% | ₹5,357 Cr | ₹626 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 62
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 81
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 64
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 71
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 7
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 62
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 23.8% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 43.8%
Weaknesses
2- Company has a low return on equity of 13.2% over last 3 years.
- Company has high debtors of 166 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 43.61
- Neutral
- MACD (12,26,9)
- −19.04
- Bullish
- SMA (50)
- 731.93
- Bearish
- SMA (200)
- 910.18
- Bearish
As of
Analyst Rating
5 of 5 analysts rate Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +15.73% |
|---|---|
| 5Y | +17.07% |
| 3Y | +9.20% |
| 1Y | +21.94% |
| TTM | +18.52% |
Net profit
| 10Y | +14.55% |
|---|---|
| 5Y | +24.35% |
| 3Y | +25.81% |
| 1Y | +124.01% |
| TTM | +49.05% |
Operating cash flow
| 10Y | +12.78% |
|---|---|
| 5Y | +21.67% |
| 3Y | +25.99% |
| 1Y | +8.61% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −2.90 pp |
|---|---|
| 5Y | +1.32 pp |
| 3Y | +3.81 pp |
| 1Y | +5.86 pp |
| TTM | +3.54 pp |
Revenue by year
| Mar 2017 | ₹1,399 Cr |
|---|---|
| Mar 2018 | ₹1,707 Cr |
| Mar 2019 | ₹1,998 Cr |
| Mar 2020 | ₹2,003 Cr |
| Mar 2021 | ₹2,396 Cr |
| Mar 2022 | ₹3,580 Cr |
| Mar 2023 | ₹4,045 Cr |
| Mar 2024 | ₹3,163 Cr |
| Mar 2025 | ₹4,320 Cr |
| Mar 2026 | ₹5,268 Cr |
Net profit by year
| Mar 2017 | ₹190 Cr |
|---|---|
| Mar 2018 | ₹191 Cr |
| Mar 2019 | ₹176 Cr |
| Mar 2020 | ₹165 Cr |
| Mar 2021 | ₹229 Cr |
| Mar 2022 | ₹349 Cr |
| Mar 2023 | ₹342 Cr |
| Mar 2024 | ₹32.00 Cr |
| Mar 2025 | ₹304 Cr |
| Mar 2026 | ₹681 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Sharda Cropchem Ltd trades at a market cap of ₹8,345 Cr with a PE of 12.1x and has delivered TTM profit growth of 128% while remaining virtually debt-free. However, the company carries high debtor days of 166 and a 3-year average ROE of only 13.6%, reflecting working capital intensity in its asset-light agrochemical distribution model.
- TTM profit growth of 128% signals a sharp earnings recovery, with 5-year compounded profit CAGR at 25%
- Company is almost debt-free, reducing financial risk and interest burden significantly
- PE of 12.1x is modest relative to 5-year profit CAGR of 25%, implying earnings are not yet fully priced in
- Healthy dividend payout of 43.8% demonstrates shareholder-friendly capital allocation with 0.66% current yield
- Last year ROE jumped to 24%, well above the 3-year average of 14%, indicating improving capital efficiency
- Compounded sales CAGR of 17% over 5 years and 16% over 10 years shows consistent top-line growth trajectory
- Stock CAGR of 20% over 5 years and 19% over 3 years reflects sustained wealth creation for long-term holders
- Asset-light model with global registrations across 80+ countries provides a wide distribution moat with low capex needs
- High debtor days of 166 indicate significant working capital blockage and potential collection risk
- 3-year average ROE of only 13.6% is below par for a debt-free company, suggesting sub-optimal capital utilization
- 1-year stock CAGR of -1% shows the market has not rewarded recent earnings growth, signaling possible skepticism about sustainability
- Revenue is largely dependent on agrochemical commodity cycles with TTM sales growth of 22% potentially reflecting cyclical tailwinds rather than structural gains
- Dividend yield of just 0.66% despite 43.8% payout ratio means absolute income generation for investors remains low
- 10-year stock CAGR of only 9% lags the broader market returns, suggesting long-term compounding has been inconsistent
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Limited recent news flow for Sharda Cropchem. The company has announced routine corporate actions with a record date for its FY26 final dividend set for August 7. No material headwinds or positive catalysts are visible from current news, leaving the near-term outlook dependent on upcoming quarterly results and agrochemical demand trends.
- Record date for FY26 dividend Jul 02
Sharda Cropchem fixed August 7, 2026 as the record date for its final dividend for FY26. The AGM is scheduled for August 14, 2026.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 638 | 581 | 632 | 1,312 | 785 | 777 | 929 | 1,829 | 985 | 929 | 1,289 | 2,065 | 1,074 | 1,052 |
| Expenses | 697 | 560 | 563 | 1,057 | 708 | 687 | 815 | 1,525 | 770 | 796 | 1,048 | 1,578 | 888 | 888 |
| Operating Profit | −59 | 21 | 69 | 255 | 77 | 90 | 115 | 303 | 215 | 133 | 241 | 487 | 186 | 164 |
| OPM % | −9% | 3.6% | 11% | 19% | 10% | 12% | 12% | 17% | 22% | 14% | 19% | 24% | 17% | 16% |
| Other Income | 26 | 24 | 12 | −2 | 19 | 25 | 1 | 25 | 32 | 29 | 21 | 22 | 35 | 45 |
| Interest | 1 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 |
| Depreciation | 70 | 74 | 69 | 54 | 65 | 69 | 69 | 72 | 78 | 76 | 83 | 87 | 100 | 100 |
| PBT | −105 | −34 | 12 | 198 | 31 | 46 | 46 | 256 | 169 | 86 | 179 | 422 | 118 | 107 |
| Tax % | −15% | −18% | 62% | 28% | 11% | 7% | 32% | 20% | 16% | 13% | 19% | 24% | 26% | 15% |
| Net Profit | −89 | −28 | 5 | 143 | 27 | 42 | 31 | 204 | 143 | 74 | 145 | 319 | 88 | 92 |
| EPS (₹) | −9.82 | −3.06 | 0.51 | 15.9 | 3.02 | 4.7 | 3.45 | 22.56 | 15.83 | 8.24 | 16.09 | 35.32 | 9.76 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,061 | 1,222 | 1,399 | 1,707 | 1,998 | 2,003 | 2,396 | 3,580 | 4,045 | 3,163 | 4,320 | 5,268 | 5,357 |
| Expenses | 878 | 941 | 1,075 | 1,343 | 1,621 | 1,653 | 1,945 | 2,884 | 3,386 | 2,860 | 3,705 | 4,209 | 4,310 |
| Operating Profit | 183 | 281 | 324 | 364 | 376 | 350 | 450 | 696 | 659 | 303 | 615 | 1,059 | 1,047 |
| OPM % | 17% | 23% | 23% | 21% | 19% | 17% | 19% | 19% | 16% | 10% | 14% | 20% | 20% |
| Other Income | 25 | 23 | 14 | 9 | −22 | −12 | 46 | 29 | 40 | 60 | 60 | 142 | 108 |
| Interest | 9 | 8 | 9 | 15 | 20 | 16 | 16 | 15 | 20 | 24 | 21 | 21 | 3 |
| Depreciation | 23 | 35 | 56 | 70 | 99 | 137 | 170 | 245 | 248 | 267 | 275 | 325 | 347 |
| PBT | 175 | 261 | 272 | 287 | 235 | 185 | 309 | 464 | 431 | 72 | 378 | 856 | 805 |
| Tax % | 30% | 33% | 30% | 34% | 25% | 11% | 26% | 25% | 21% | 56% | 20% | 20% | — |
| Net Profit | 123 | 175 | 190 | 191 | 176 | 165 | 229 | 349 | 342 | 32 | 304 | 681 | 626 |
| EPS (₹) | 13.63 | 19.41 | 21.11 | 21.14 | 19.55 | 18.25 | 25.4 | 38.71 | 37.9 | 3.53 | 33.74 | 75.47 | 69.41 |
| Div. Payout % | 18% | 21% | 19% | 19% | 20% | 22% | 20% | 16% | 16% | 85% | 27% | 20% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
| Reserves | 564 | 715 | 870 | 1,045 | 1,194 | 1,313 | 1,524 | 1,822 | 2,142 | 2,147 | 2,410 | 3,046 |
| Borrowings | 38 | 2 | 0 | 170 | 0 | 0 | 81 | 47 | 3 | 18 | 8 | 0 |
| Other Liabilities | 354 | 522 | 686 | 914 | 914 | 940 | 1,163 | 1,779 | 2,108 | 1,773 | 2,205 | 2,620 |
| Total Liabilities | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
| Fixed Assets | 88 | 130 | 210 | 226 | 372 | 416 | 544 | 592 | 668 | 708 | 750 | 989 |
| CWIP | 149 | 210 | 232 | 360 | 220 | 161 | 131 | 212 | 204 | 283 | 291 | 247 |
| Investments | 95 | 90 | 61 | 22 | 212 | 116 | 83 | 134 | 32 | 159 | 294 | 361 |
| Other Assets | 715 | 899 | 1,143 | 1,611 | 1,394 | 1,650 | 2,099 | 2,800 | 3,439 | 2,878 | 3,377 | 4,159 |
| Total Assets | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 46 | 197 | 181 | 17 | 556 | 146 | 246 | 267 | 328 | 341 | 604 | 656 |
| Investing | −19 | −113 | −104 | −160 | −351 | −59 | −282 | −205 | −112 | −393 | −496 | −445 |
| Financing | −24 | −89 | −38 | 132 | −215 | −60 | 43 | −91 | −97 | −37 | −68 | −118 |
| Net Cash Flow | 3 | −6 | 40 | −11 | −11 | 27 | 8 | −29 | 120 | −89 | 40 | 93 |
| Free Cash Flow | −34 | 196 | 39 | −185 | 413 | −30 | 15 | 33 | 84 | 69 | 211 | 158 |
| CFO/EBITDA | 58 | 95 | 73 | 27 | 169 | 60 | 68 | 49 | 60 | 129 | 103 | 68 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 156 | 185 | 175 | 191 | 148 | 180 | 177 | 157 | 165 | 173 | 165 | 166 |
| Inventory Days | 72 | 74 | 117 | 169 | 96 | 100 | 117 | 130 | 145 | 155 | 117 | 121 |
| Days Payable | 117 | 179 | 186 | 202 | 167 | 180 | 180 | 172 | 176 | 144 | 158 | 162 |
| Cash Conversion Cycle | 111 | 81 | 106 | 158 | 77 | 100 | 114 | 115 | 134 | 184 | 124 | 125 |
| Working Capital Days | 82 | 95 | 99 | 94 | 71 | 101 | 94 | 88 | 97 | 128 | 92 | 102 |
| ROCE % | 27% | 36% | 32% | 27% | 23% | 18% | 21% | 26% | 21% | 4% | 16% | 30% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sharda Cropchem insights
64 extracted metrics across FY13–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 23 Feb 2026
- 10 Mar 2025
- 13 Feb 2024
- 21 Aug 2023
- 5 Jul 2022
- General announcements 30 Oct 2026
Frequently Asked Questions about Sharda Cropchem
What does Sharda Cropchem Ltd do?
Where is Sharda Cropchem Ltd (SHARDACROP) listed?
Which sector does Sharda Cropchem Ltd belong to?
What is the PE ratio of Sharda Cropchem Ltd?
What is the 52-week high and low of Sharda Cropchem Ltd?
Does Sharda Cropchem Ltd pay dividends?
What is the Return on Equity (ROE) of Sharda Cropchem Ltd?
Company Information
Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHARDACROP.md for Sharda Cropchem Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.